Drugs that contain Clobazam

1. Sympazan patents expiration

SYMPAZAN's oppositions filed in EPO
SYMPAZAN IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 OTTER PHARMS Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2024

(3 months ago)

US8603514 OTTER PHARMS Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(a month ago)

US11541002 OTTER PHARMS Oral film compositions and dosage forms having precise active dissolution profiles
Jan, 2040

(15 years from now)

Market Authorisation Date: 01 November, 2018

Treatment: Method of treating seizures


More Information on Dosage

SYMPAZAN family patents

Family Patents